Quantcast

Latest pharmaceutical Stories

2014-10-16 08:31:37

TORONTO, Oct. 16, 2014 /PRNewswire/ - Highland Therapeutics Inc. ("Highland"), a pharmaceutical company, today announced it has completed a US$25 million offering of Class A Common Shares. The financing was led by a private equity partner that is committed to Highland's long-term success. The funds raised will provide, among other things, the necessary resources for Highland, through its wholly owned subsidiary Ironshore Pharmaceuticals & Development, Inc. to (i) complete the...

2014-10-16 08:31:11

-- Go Dropless(TM) campaign continues its momentum as cataract surgeons embrace the benefits of "going dropless" for their patients -- SAN DIEGO, Oct. 16, 2014 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), a specialty pharmaceutical company focused on the development and commercialization of high quality and innovative sterile and topical compounded drug formulations, today announces its attendance, and related "Go Dropless!(TM)" events, at the 2014 American Academy...

2014-10-15 20:22:42

Company to make OFEV available to IPF community within 10 days, along with comprehensive patient support resources RIDGEFIELD, Conn., Oct. 15, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved OFEV® (nintedanib) capsules for oral use for the treatment of idiopathic pulmonary fibrosis (IPF). Granted Breakthrough Therapy designation during its review by the FDA, OFEV, capsules for oral use, taken twice...

2014-10-14 08:32:16

Distinguished research and clinical scientists team to unlock genome sequencing data SAN DIEGO, Oct. 14, 2014 /PRNewswire/ -- Cypher Genomics, Inc., the genome informatics company, announced today the formation of a scientific advisory board (SAB) to guide the development and implementation of Cypher's products, which include Mantis(TM), the genome interpretation software as a service offering, and Coral(TM), a biomarker discovery service. Drs. Kelly Bethel, Michael Hultner, Myla...

2014-10-02 20:22:35

NORTHBROOK, Ill., Oct. 2, 2014 /PRNewswire/ -- Astellas, a pharmaceutical company based in Northbrook, Ill., launched a new benefits program today to provide support for its almost 3,000 US-based employees. The program goes beyond traditional healthcare support to include legal aid for parents and in-laws, identity theft for the entire family and college coaching in addition to many other benefits. http://photos.prnewswire.com/prnvar/20140416/84970 "We recognize in life there's a...

2014-10-01 16:27:41

SAN DIEGO, Oct. 1, 2014 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that Malcolm Lloyd-Smith has joined the executive management team as Chief Regulatory Officer. "We are very pleased to welcome Malcolm Lloyd-Smith to the Neurocrine leadership team as our Chief Regulatory Officer," said Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences. "Malcolm brings a wealth of worldwide regulatory experience and pharmaceutical...

2014-10-01 08:31:09

SHANGHAI, Oct. 1, 2014 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (WuXi) (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device research and development outsourcing company with operations in China and the United States, announced today that it has acquired XenoBiotic Laboratories, Inc. (XBL), a contract research organization with 27 years of successful operation that provides bioanalytical, drug metabolism, and pharmacokinetic services to the pharmaceutical,...

2014-09-30 23:10:20

ReportsnReports.com adds “Laboratory Filtration Market by Technology (Ultrafiltration, Microfiltration, and Reverse Osmosis), Product (Filter Assembly, Filter Media), Accessories (Dispenser, Seal, Filter Flask, Vacuum Pump) & by End-User - Global Forecasts to 2019" global research report to its store. (PRWEB) September 30, 2014 Over the last decade, the laboratory filtration market is experiencing growth primarily due to rising R&D budgets and increased acceptance of new...

2014-09-29 08:30:12

A single ILUVIEN implant provides treatment for three years ATLANTA, Sept. 29, 2014 /PRNewswire/ -- Alimera Sciences, Inc. (NASDAQ: ALIM) ("Alimera"), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it will hold a conference call to provide additional information regarding the recent approval by the U.S. Food and Drug Administration (FDA) of ILUVIEN(®) for the treatment of...

2014-09-28 23:02:30

DotComWebDesign Announces New Pharmaceutical Marketing Services (PRWEB) September 28, 2014 DotComWebDesign, the premier digital marketing agency, is pleased to announce the addition of Pharmaceutical marketing services to its wide array of diverse services. With experience doing B2C marketing, DotcomWebDesign can help pharmaceutical companies connect with their target audience. Using a variety of mediums, ranging from traditional advertising, to more complicated mediums such as social...


Word of the Day
bellycheer
  • Good cheer; viands.
  • To revel; to feast.
The word 'bellycheer' may come from 'belle cheer', "good cheer".
Related